Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

109.34
-1.7650-1.59%
Volume:118.17K
Turnover:12.93M
Market Cap:6.12B
PE:-26.58
High:111.28
Open:110.08
Low:105.05
Close:111.10
52wk High:117.88
52wk Low:22.81
Shares:55.93M
Float Shares:55.87M
Volume Ratio:1.09
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1130
EPS(LYR):-4.2037
ROE:-26.07%
ROA:-17.69%
PB:5.22
PE(LYR):-26.01

Loading ...

Wells Fargo Remains a Buy on Dianthus Therapeutics (DNTH)

TIPRANKS
·
Apr 01

Dianthus Therapeutics (DNTH) Receives a Buy from Wells Fargo

TIPRANKS
·
Mar 27

Dianthus Therapeutics; Director Paula Soteropoulos drops 27,594 common shares worth $2,153,736

Reuters
·
Mar 27

Dianthus Therapeutics- Proposed Changes to Screening Criteria Related to Claseprubart Trials to FDA in Q1 2026 - SEC Filing

THOMSON REUTERS
·
Mar 26

U.S. RESEARCH ROUNDUP-Carnival, Five Below, McKesson

Reuters
·
Mar 19

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH) and Minerva Neurosciences (NERV)

TIPRANKS
·
Mar 16

Dianthus Chief Accounting Officer Edward Carr Disposes of Common Shares

Reuters
·
Mar 14

Dianthus price target raised to $103 from $80 at Wedbush

TIPRANKS
·
Mar 12

Analysts Have Conflicting Sentiments on These Healthcare Companies: Nanobiotix (NBTX), ImageneBio (IMA) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
Mar 12

Dianthus Therapeutics prices upsized follow-on offering at USD 625 million

Reuters
·
Mar 11

Dianthus Therapeutics Inc - Prices Upsized Offering of 7,313,582 Shares at $81.00 per Share

THOMSON REUTERS
·
Mar 11

Stock Track | Dianthus Therapeutics Soars 5.09% Intraday on Multiple Analyst Upgrades and Price Target Increases

Stock Track
·
Mar 11

Dianthus price target raised to $80 from $55 at Wedbush

TIPRANKS
·
Mar 10

Dianthus Therapeutics Inc : Raymond James Raises to Strong Buy From Outperform; Raises Target Price to $123 From $63

THOMSON REUTERS
·
Mar 10

U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, FedEx

Reuters
·
Mar 10

AI Integration Exposes Dianthus Therapeutics to Heightened Cyber, Privacy, and Reputational Risks

TIPRANKS
·
Mar 10

BRIEF-Dianthus Therapeutics Announces Proposed $400 Million Underwritten Public Offering

Reuters
·
Mar 10

Dianthus Therapeutics Shares Down 4.1% After the Bell; Announces Proposed $400 Million Underwritten Public Offering

THOMSON REUTERS
·
Mar 10

Dianthus announces $400M common stock offering

TIPRANKS
·
Mar 10

Dianthus Therapeutics Inc - to Use Net Proceeds for Clinical, Commercial, Working Capital, and Corporate Purposes

THOMSON REUTERS
·
Mar 10